{
  "id": 19837971,
  "title": "Windward Bio hits Nasdaq with $175M IPO, plus another $50M from Sanofi",
  "url": "https://urgent.news/2026/11/13/windward-bio-hits-nasdaq-with-175m-ipo-plus-another-50m-from-sanofi",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-13T16:30:30.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/windward-bio-hits-nasdaq-with-175m-ipo-plus-another-50m-from-sanofi/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Windward Bio, a biotech developing drugs for respiratory diseases, made its public debut after putting together $175 million in its IPO. The company began trading Friday with an initial share price {$WWB} of $17 apiece ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}